Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (171-180 of 490) with videos related to

Pageof 49
Sort By:
British Journal of Cancer|November 11, 2018
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progressionChristopher Groth, Xiaoying Hu, Rebekka Weber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 1, 2019
5. Netzwerktreffen der zertifizierten HautkrebszentrenJochen Utikal, Thomas Eigentler, Margit Anna Huber, et al.
Seminars in Immunopathology|October 28, 2016
Myeloid-derived suppressor cells and tumor escape from immune surveillanceViktor Umansky, Carolin Blattner, Viktor Fleming, et al.
International Journal of Dermatology|March 19, 2015
Acid citrate dextrose extracorporeal photopheresis is an alternative treatment option for patients with heparin allergySimone Stadler, Nina Booken, Stefan W Schneider, et al.
Plos One|July 16, 2015
Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide EpitopesTania Køllgaard, Selma Ugurel-Becker, Manja Idorn, et al.
Carcinogenesis|January 15, 2015
TRIB2 as a biomarker for diagnosis and progression of melanomaRichard Hill, Ravi Kiran Reddy Kalathur, Laura Colaço, et al.
European Journal of Dermatology : EJD|September 20, 2013
Chronic perianal ulceration as the initial symptom of Langerhans cell histiocytosis in adultsLidia M Poppe, Philip A Müller, Heiko Poppe, et al.
Frontiers in Oncology|December 2, 2020
Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case ReportJohanna Matull, Elisabeth Livingstone, Axel Wetter, et al.
Frontiers in Immunology|March 3, 2025
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation statusJan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, et al.
Cancer Research|June 17, 2006
Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease durationJan Müller-Berghaus, Katrin Ehlert, Selma Ugurel, et al.
Pageof 49

Showing results (171-180 of 490) with videos related to

Sort By:
Pageof 49
British Journal of Cancer|November 11, 2018
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progressionChristopher Groth, Xiaoying Hu, Rebekka Weber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 1, 2019
5. Netzwerktreffen der zertifizierten HautkrebszentrenJochen Utikal, Thomas Eigentler, Margit Anna Huber, et al.
Seminars in Immunopathology|October 28, 2016
Myeloid-derived suppressor cells and tumor escape from immune surveillanceViktor Umansky, Carolin Blattner, Viktor Fleming, et al.
International Journal of Dermatology|March 19, 2015
Acid citrate dextrose extracorporeal photopheresis is an alternative treatment option for patients with heparin allergySimone Stadler, Nina Booken, Stefan W Schneider, et al.
Plos One|July 16, 2015
Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide EpitopesTania Køllgaard, Selma Ugurel-Becker, Manja Idorn, et al.
Carcinogenesis|January 15, 2015
TRIB2 as a biomarker for diagnosis and progression of melanomaRichard Hill, Ravi Kiran Reddy Kalathur, Laura Colaço, et al.
European Journal of Dermatology : EJD|September 20, 2013
Chronic perianal ulceration as the initial symptom of Langerhans cell histiocytosis in adultsLidia M Poppe, Philip A Müller, Heiko Poppe, et al.
Frontiers in Oncology|December 2, 2020
Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case ReportJohanna Matull, Elisabeth Livingstone, Axel Wetter, et al.
Frontiers in Immunology|March 3, 2025
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation statusJan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, et al.
Cancer Research|June 17, 2006
Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease durationJan Müller-Berghaus, Katrin Ehlert, Selma Ugurel, et al.
Pageof 49